aTyr Pharma reported 79.65M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Ardelyx USD 5.76M 37K Dec/2025
aTyr Pharma 79.65M 78.89M Mar/2026
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 411M 21M Mar/2026
Cipla INR 131.3M 9M Mar/2026
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
GlaxoSmithKline GBP 167M 21M Mar/2026
Grifols EUR 156.07M 31.46M Sep/2025
Lakefront Biotherapeutics EUR 1.72M 940K Sep/2025
Novartis USD 343M 39M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024